Phreesia, Inc. (NYSE:PHR) SVP Amy Beth Vanduyn Sells 685 Shares

Phreesia, Inc. (NYSE:PHR) SVP Amy Beth Vanduyn sold 685 shares of the firm’s stock in a transaction that occurred on Monday, April 15th. The stock was sold at an average price of $22.86, for a total value of $15,659.10. Following the transaction, the senior vice president now owns 119,010 shares in the company, valued at $2,720,568.60. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink.

Amy Beth Vanduyn also recently made the following trade(s):

• On Monday, April 8th, Amy Beth Vanduyn sold 3,354 shares of Phreesia stock. The stock was sold at an average price of $22.62, for a total transaction of $75,867.48.

Phreesia Stock Performance

Shares of Phreesia stock opened at $22.62 on Friday. Phreesia, Inc. has a 12 month low of $12.05 and a 12 month high of $34.98. The company has a debt-to-equity ratio of 0.02, a current ratio of 1.78 and a quick ratio of 1.78. The business has a fifty day simple moving average of $24.40 and a two-hundred day simple moving average of $21.26.

Phreesia (NYSE:PHR) last issued its quarterly earnings results on Thursday, March 14th. The company reported ($0.56) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.58) by $0.02. The company had revenue of $95.00 million during the quarter, compared to analysts’ expectations of $93.52 million. Phreesia had a negative net margin of 38.42% and a negative return on equity of 53.33%. Phreesia’s revenue was up 24.0% on a year-over-year basis. During the same period last year, the company posted ($0.72) EPS. On average, research analysts expect that Phreesia, Inc. will post -1.48 earnings per share for the current year.

Analysts Set New Price Targets

PHR has been the topic of a number of recent analyst reports. Stephens reissued an “overweight” rating and issued a $28.00 price target on shares of Phreesia in a report on Friday, March 22nd. Needham & Company LLC restated a “buy” rating and set a $29.00 price target on shares of Phreesia in a report on Friday, March 15th. Truist Financial started coverage on Phreesia in a research report on Monday, February 26th. They set a “buy” rating and a $35.00 price target for the company. Robert W. Baird boosted their target price on Phreesia from $30.00 to $31.00 and gave the company an “outperform” rating in a research note on Monday, March 18th. Finally, Raymond James restated an “outperform” rating and set a $30.00 target price (up previously from $25.00) on shares of Phreesia in a report on Friday, March 15th. Two research analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company’s stock. According to MarketBeat, Phreesia currently has an average rating of “Moderate Buy” and a consensus target price of $31.62.

Institutional Trading of Phreesia

A number of hedge funds have recently made changes to their positions in the stock. Envestnet Asset Management Inc. raised its stake in Phreesia by 11.7% during the first quarter. Envestnet Asset Management Inc. now owns 9,692 shares of the company’s stock valued at $255,000 after buying an additional 1,015 shares during the last quarter. JPMorgan Chase & Co. raised its position in shares of Phreesia by 160.9% in the 1st quarter. JPMorgan Chase & Co. now owns 85,546 shares of the company’s stock worth $2,254,000 after purchasing an additional 52,755 shares during the last quarter. Raymond James Financial Services Advisors Inc. boosted its stake in Phreesia by 20.7% in the 1st quarter. Raymond James Financial Services Advisors Inc. now owns 8,427 shares of the company’s stock worth $222,000 after purchasing an additional 1,447 shares in the last quarter. Bank of New York Mellon Corp increased its stake in Phreesia by 0.9% during the 1st quarter. Bank of New York Mellon Corp now owns 219,598 shares of the company’s stock valued at $5,788,000 after purchasing an additional 2,047 shares in the last quarter. Finally, PNC Financial Services Group Inc. raised its holdings in Phreesia by 27.6% in the first quarter. PNC Financial Services Group Inc. now owns 16,059 shares of the company’s stock worth $424,000 after buying an additional 3,473 shares during the last quarter. 92.10% of the stock is owned by institutional investors.

Phreesia Company Profile

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.